These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7544484)

  • 1. Standardization of PSA determinations.
    Stenman UH; Leinonen J; Zhang WM
    Scand J Clin Lab Invest Suppl; 1995; 221():45-51. PubMed ID: 7544484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems in the determination of prostate specific antigen.
    Stenman UH; Leinonen J; Zhang WM
    Eur J Clin Chem Clin Biochem; 1996 Sep; 34(9):735-40. PubMed ID: 8891526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of free prostate-specific antigen (PSA) after chemical release from the complex with alpha(1)-antichymotrypsin (PSA-ACT).
    Peter J; Unverzagt C; Hoesel W
    Clin Chem; 2000 Apr; 46(4):474-82. PubMed ID: 10759471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer: WHO standardization of PSA tests: clinical consequences.
    Stephan C
    Nat Rev Urol; 2009 Jun; 6(6):303-5. PubMed ID: 19498407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues on standardization of immunoassays for prostate-specific antigen: a review.
    Graves HC
    Clin Invest Med; 1993 Dec; 16(6):415-24. PubMed ID: 7516830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual prostate-specific antigen (PSA) forms as prostate tumor markers.
    Becker C; Lilja H
    Clin Chim Acta; 1997 Jan; 257(1):117-32. PubMed ID: 9028629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer.
    Christensson A; Björk T; Nilsson O; Dahlén U; Matikainen MT; Cockett AT; Abrahamsson PA; Lilja H
    J Urol; 1993 Jul; 150(1):100-5. PubMed ID: 7685416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin: potential reference material for international standardization of PSA immunoassays.
    Chen Z; Prestigiacomo A; Stamey TA
    Clin Chem; 1995 Sep; 41(9):1273-82. PubMed ID: 7544704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disagreement between the Roche Cobas Core and Hybritech TANDEM-E PSA assays when measuring free, complexed and total serum prostate specific antigen.
    Tillyer CR; Konings M; Gobin PT; Iqbal J
    Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():501-5. PubMed ID: 7530440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the serum prostate-specific antigen-alpha 1-antichymotrypsin complex and its density as a predictor for the extent of prostate cancer.
    Hara I; Miyake H; Hara S; Yamanaka N; Ono Y; Eto H; Takechi Y; Arakawa S; Kamidono S
    BJU Int; 2001 Jul; 88(1):53-7. PubMed ID: 11446846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A universal calibrator for prostate specific antigen (PSA).
    Prestigiacomo AF; Chen Z; Stamey TA
    Scand J Clin Lab Invest Suppl; 1995; 221():57-9. PubMed ID: 7544486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of serum prostate-specific antigen-alpha1-antichymotrypsin complex for diagnosis of prostate cancer in Japanese cases.
    Kuriyama M; Abrahamsson PA; Imai K; Akimoto S; Deguchi N; Shichiri Y; Sugiyama Y; Niwa T; Inoue T
    Scand J Urol Nephrol; 2001 Feb; 35(1):5-10. PubMed ID: 11291689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum.
    Lilja H; Cockett AT; Abrahamsson PA
    Cancer; 1992 Jul; 70(1 Suppl):230-4. PubMed ID: 1376193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker development, from bench to bedside.
    Stenman UH
    Crit Rev Clin Lab Sci; 2016; 53(2):69-86. PubMed ID: 26287282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.
    Lilja H; Christensson A; Dahlén U; Matikainen MT; Nilsson O; Pettersson K; Lövgren T
    Clin Chem; 1991 Sep; 37(9):1618-25. PubMed ID: 1716536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant prostate specific antigen test results despite WHO assay standardization.
    Boegemann M; Arsov C; Hadaschik B; Herkommer K; Imkamp F; Nofer JR; Gerß J; Albers P; Semjonow A
    Int J Biol Markers; 2018 Aug; 33(3):275-282. PubMed ID: 29734838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostate-specific antigen (PSA), PSA-ACT, free PSA and F/T].
    Kuriyama M
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():694-7. PubMed ID: 16149614
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin.
    Lilja H
    Urol Clin North Am; 1993 Nov; 20(4):681-6. PubMed ID: 7505976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
    Stenman UH; Leinonen J; Alfthan H; Rannikko S; Tuhkanen K; Alfthan O
    Cancer Res; 1991 Jan; 51(1):222-6. PubMed ID: 1703033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of prostate-specific antigen (PSA) assays: can interchangeability of PSA measurements be improved?
    Ishibashi M
    Clin Chem; 2006 Jan; 52(1):1-2. PubMed ID: 16391325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.